Applications

Application / Healthcare

Quantum in Healthcare.

Personalized medicine, drug discovery, and protein folding.

Quantum computers can model molecules and proteins directly, instead of approximating them. That unlocks personalized medicine, faster drug candidates, and treatments tailored to individual genetics.

Drugs Designed On Quantum Hardware

Pharma is already prototyping drug candidates using quantum simulations of small biomolecules.

Why quantum, why now.

  • Molecules obey quantum mechanics — classical computers can only approximate them.
  • A useful quantum computer simulates chemistry natively, not with brute force.
  • Even early machines can already tackle small biomolecules that stump supercomputers.

Timeline — past and future.

What already happened, and what's next for quantum healthcare.

  1. 1981

    Feynman proposes quantum computers to simulate biology and chemistry.

  2. 2016

    Google/Harvard simulate hydrogen molecule H₂ on a superconducting quantum computer.

  3. 2020

    IBM + Roche partner on quantum for drug discovery.

  4. 2023

    Quantinuum + Boehringer Ingelheim publish first quantum-native drug discovery workflow.

  5. 2025

    Google Willow chip runs error-corrected molecular simulations.

  6. 2027Forecast

    First quantum-assisted drug candidate enters phase-1 clinical trial.

  7. 2030Forecast

    Routine simulation of small proteins (100–200 residues) at quantum accuracy.

  8. 2033Forecast

    Personalized cancer therapies designed against a patient's specific tumor mutations.

  9. 2040Forecast

    Quantum-designed antibiotics enter the global formulary.

Where it hits.

Drug discovery

Screen candidate molecules by simulating their interactions with target proteins directly.

Protein folding

Predict 3D structures for proteins that AlphaFold-style models still get wrong.

Personalized medicine

Model how a specific patient's genetic variants respond to a compound.

Medical imaging

Quantum machine learning speeds up MRI reconstruction and diagnostic pattern recognition.

What's already happening.

  • Quantum-inspired MRI reconstruction in commercial scanners today.
  • Pharma R&D pilots at Roche, Merck, Boehringer, Pfizer, Cleveland Clinic.
  • Variational Quantum Eigensolver (VQE) already computing ground-state energies for small drug fragments.
  • Quantum ML pilots for medical imaging classification (radiology, pathology).

Companies in quantum healthcare.

Who's actually building here — hardware makers, industry partners, and pure-play startups.

Google Quantum AI

Willow chip demonstrated first below-threshold error correction — a milestone for chemistry.

IBM Quantum

Deep pharma partnerships (Cleveland Clinic, Moderna, Boehringer).

Quantinuum

Trapped-ion hardware paired with the InQuanto drug-discovery software stack.

PsiQuantum

Betting on photonic FTQC scale as the shortest path to real biology.

Roche

First big pharma to publicly partner on quantum drug discovery (with Cambridge Quantum).

Moderna

Working with IBM on quantum + generative AI for mRNA design.

Ecosystem highlights

Google Quantum AIIBM QuantumQuantinuumPsiQuantumRocheBoehringer Ingelheim
Time horizon

First useful advantage: 3–7 years for narrow molecular simulation.

Interesting corners.

  • Life happens at ~310 K, where thermal noise obscures the quantum effects proteins actually exploit.
  • The 'chemical accuracy' bar is ~1 kcal/mol — beyond most classical DFT methods, achievable by quantum.
  • Drug discovery costs ~$2B per approved molecule; quantum aims to move ~40% of that cost upstream into simulation.
  • The biggest early win won't be a new drug — it'll be reliably ruling out molecules that would have failed in trials.
Previous
Materials Science
Next
Finance